In breast cancer [86], exosomal miR-92 acts on the LATS2-YAP1 axis, thereby increasing the transcription level of PD-L1 in cancer cells, ultimately inducing T cell apoptosis and proliferation disorders, and blocking the killing function of NK cells (Fig. 4d). This evidence concerns the gene LATS2 and cancer.